Periodic Reporting for period 3 - PRIME (Prevention and Remediation of Insulin Multimorbidity in Europe)

PRIME addresses insulin signalling as a novel and key modulator of comorbid mental and nonmental diseases. Dysregulation of insulin signalling has been implicated in multimorbidity across the lifespan, in particular in type 2 diabetes (DM2), metabolic syndrome (MetS), and...